ProShares Ultra Nasdaq Biotechnology ETF
ProShares Ultra Nasdaq Biotechnology ETF
BIB

ProShares Ultra Nasdaq Biotechnology ETF (BIB)

$91.473.65%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$91.47
Today Low/High$91.47 / $91.47
52 Week Low/High$62.45 / $113.06
Market Cap$220.62M
Expense Ratio0.0095
Total Assets$270.42M

Top 10 Holdings

Moderna Inc
Moderna Inc
9.29%
Gilead Sciences Inc
Gilead Sciences Inc
5.61%
Amgen Inc
Amgen Inc
5.52%
Illumina Inc
Illumina Inc
4.1%
Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc
3.9%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.19%
Biogen Inc
Biogen Inc
3.16%
Seagen Inc
Seagen Inc
1.88%
BioNTech SE
BioNTech SE
1.62%
Horizon Therapeutics Public Limited Company
Horizon Therapeutics Public Limited Company
1.5%

  • Assets

Region breakup

United Kingdom
United Kingdom
1.79%

About the ETF

About ProShares

About ProShares

ProShares has 43 ETFs with total asset size of $53.96B.
Nasdaq 100 ETF

Nasdaq 100 ETF

This ETF tracks Nasdaq 100. The Nasdaq-100 Index (NDX) is a collection of the largest 100 non-financial companies in the world listed on the Nasdaq exchange.
Assets Managed

Assets Managed

ProShares Ultra Nasdaq Biotechnology was started on 2010 and has accumulated $270.42M in assets managed.

Discover more

Frequently Asked Questions

What is ProShares Ultra Nasdaq Biotechnology ETF (BIB) share price today?

Can Indians buy ProShares Ultra Nasdaq Biotechnology ETF (BIB) shares?

How can I buy ProShares Ultra Nasdaq Biotechnology ETF (BIB) shares from India?

Can Fractional shares of ProShares Ultra Nasdaq Biotechnology ETF (BIB) be purchased?

What are the documents required to start investing in ProShares Ultra Nasdaq Biotechnology ETF (BIB) stocks?

We are a SEBI registered investement advisor